3,7,12-trihydroxycoprostane has been researched along with Brain Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freese, DK; Hanson, RF | 1 |
| Björkhem, I; Buchmann, MS; East, C; Grundy, S; Kvittingen, EA; Lie, SO; Skrede, S | 1 |
1 review(s) available for 3,7,12-trihydroxycoprostane and Brain Disorders
| Article | Year |
|---|---|
Neonatal cholestatic syndromes associated with alterations in bile acid synthesis.
Topics: Abnormalities, Multiple; Bile Acids and Salts; Bile Ducts, Intrahepatic; Brain Diseases; Cholestanols; Cholestasis; Genes, Recessive; Hepatomegaly; Humans; Infant, Newborn; Jaundice, Neonatal; Lipid Metabolism, Inborn Errors; Polycystic Kidney Diseases; Syndrome; Xanthomatosis | 1983 |
1 other study(ies) available for 3,7,12-trihydroxycoprostane and Brain Disorders
| Article | Year |
|---|---|
Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis.
Topics: Brain Diseases; Cells, Cultured; Cholestanetriol 26-Monooxygenase; Cholestanols; Female; Fibroblasts; Humans; Hydroxycholesterols; Hydroxylation; Kinetics; Male; Middle Aged; Steroid Hydroxylases; Substrate Specificity; Xanthomatosis | 1986 |